The importance of kinin antagonist treatment timing in closed head trauma

Journal of Trauma

Volumn 51, Issue 5, 2001, Pages 944-948

  Rachinsky, Maxim ^a   Pruneau, Didier ^b   Artru, Alan A ^c   Kapuler, Vadim ^a   Alonchin, Andrei ^a   Smolanezki, Yuri ^a   Shapira, Yoram ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Laboratoires Fournier SA   (France)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bradykinin B2 antagonist; Cerebral edema; Head injury; Neurologic outcome; Rat

Indexed keywords

1 [3 [(2,4 DIMETHYLQUINOLIN 8 YLOXYMETHYL) DEXTRO 2,4 DICHLOROPHENYL]SULFONYL] N 3 [[4 (AMINOIMINOMETHYLPHENYL)CARBONYLAMINO]PROPYL]PYRROLIDINECARBOXAMIDE DIMESYLATE; BRADYKININ B2 RECEPTOR ANTAGONIST; LF 160687 MS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN WATER; CONTROLLED STUDY; DISEASE SEVERITY; HEAD INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

EID: 0035210176     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200111000-00020     Document Type: Article

References (30)

1. Hess JF, Borkowski JA, Young GS, et al. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992; 184: 260-268.
2. 1 bradykinin receptor. J Biol Chem. 1994; 269: 21583-21586.
3. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980; 32: 1-46.
4. Dodey P, Bondoux M, Ou K, et al. Novel N-benzenesulphonyl-L-proline derivatives, method for preparing and therapeutic use. U.S. patent WO9824783. June 11, 1998.
5. Dodey P, Pruneau D, Barth M, et al. New nonpeptide bradykinin B2 receptor antagonists. In: The 13th French-Japanese Symposium on Medicinal and Fine Chemistry; May 25-28, 1998; Shonan Village Center, Hayama, Kanagawa, Japan.
6. Unterberg A, Dautermann C, Baethmann A, Müller-Esterl W. The kallikrein-kinin system as mediator in vasogenic brain edema, part 3: inhibition of the kallikrin-kinin system in traumatic brain swelling. J Neurosurg. 1986; 64: 269-276.
7. Kamiya T, Katayama Y, Kashiwagi F, Terashi A. The role of bradykinin in mediating ischemic brain edema in rats. Stroke. 1993; 24: 571-576.
8. Narotam PK, Nadvi SS, Bhoola KD, et al. Traumatic brain contusion: a clinical role for a kinin antagonist in reducing secondary brain swelling. J Neurosurg. 1995; 82: 350A.
9. Pruneau D, Chorny I, Benkovitz V, et al. Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma. J Neurotrauma. 1999; 16: 1057-1065.
10. Shapira Y, Setton D, Artru AA, Shohami E. Blood-brain barrier permeability, cerebral edema, and neurologic function after closed head injury in rats. Anesth Analg. 1993; 77: 141-148.
11. Talmor D, Roytblat L, Artru AA, et al. Phenylephrine-induced hypertension does not improve outcome after closed head trauma in rats. Anesth Analg. 1998; 87: 574-578.
12. Chorny I, Bsorai R, Artru AA, et al. Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats. J Neurosurg Anesth. 1999; 11: 273-281.
13. Feldman Z, Gurevitch B, Artru AA, et al. Neurologic outcome with hemorrhagic hypotension after closed head trauma in rats: effect of early versus delayed conservative fluid therapy. J Trauma. 1997; 43: 667-672.
14. Raidoo DM, Bhoola KD. Kinin receptors on human neurones. J Neuroimmunol. 1997; 77: 39-44.
15. Maier-Hauff K, Baethmann AJ, Lange M, et al. The kallikrein-kinin system as a mediator in vasogenic brain edema, part 2: studies on kinin formation in focal and perifocal brain tissue. J Neurosurg. 1984; 61: 97-106.
16. Ellis EF, Chao J, Heizer ML. Brain kininogen following experimental brain injury: evidence for a secondary event. J Neurosurg. 1989; 61: 97-106.
17. Xu J, Hsu CY, Junker H, et al. Kininogen and kinin in experimental spinal cord injury. J Neurochem. 1991; 57: 975-980.
18. Sobey CG, Heistad DD, Faraci FM. Mechanisms of bradykinin-induced cerebral vasodilatation in rats: evidence that reactive oxygen species activate K+ channels. Stroke. 1997; 28: 2290-2295.
19. Görlach C, Wahl M. Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide. Peptides. 1996; 17: 1373-1378.
20. Mayham WG. Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension. Brain Res. 1996; 738: 337-341.
21. Wahl M, Schilling L, Unterberg A, Baethmann A. Mediators of vascular and parenchymal mechanisms in secondary brain damage. Acta Neurochir. 1993; 57 (suppl): 64-72.
22. Schilling L, Wahl M. Brain edema: pathogenesis and therapy. Kidney Int. 1997; 51 (suppl 59): S69-S75.
23. Unterberg A, Wahl M, Baethmann A. Effects of bradykinin on permeability and diameter of pial vessels in vivo. J Cereb Blood Flow Metab. 1984; 4: 574-585.
24. Ellis EF, Holt SA, Wei IP, Kontos HA. Kinins induced abnormal vascular reactivity. Am J Physiol. 1988; 255: H397-H400.
25. Gecse A, Mezei Z, Telegdy G. The effect of bradykinin and its fragments on the arachidonate cascade of brain microvessels. Adv Exp Med Biol. 1989; 247A: 249-254.
26. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke. 1993; 24: 392-399.
27. Parpura V, Basarsky TA, Liu F, et al. Glutamate-mediated astrocyte-neuron signalling. Nature. 1994; 369: 744-747.
28. Jeftinija S, Jeftinija KV, Stefanovic G, et al. Neuroligand-evoked calcium-dependent release of excitatory amino acids from cultured astrocytes. J Neurochem. 1996; 66: 676-684.
29. Narotam PK, Rodell TC, Nadvi SS, et al. Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127. Acta Neurochir. 1998; 140: 793-802.
30. Marmarou A, Nichols J, Burgess J, et al. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial—American Brain Injury Consortium Study Group. J Neurotrauma. 1999; 16: 431-444.